Seroepidemiologic study on lyme borreliosis in isparta region in Turkey

Seroepidemiologic study on lyme borreliosis in isparta region in Turkey

The frequency of anti-Borrelia burgdorferi antibodies in human sera of people from Isparta region was studied. In this study, seroprevalance of IgG and IgM antibodies in 365 blood samples collected between June and September 2005, regardless of age and gender of the people who live within the borders of Province of Isparta in Turkey and who are engaged in farming through ELISAmethod was examined. The sera determined as IgG positive through ELISA were confirmed by Western Blot. Anti Borrelia burgdorferi antibodies were detected as an IgG positivity 12 (3.28%) in 365 blood samples was found in 143 men, 5 of 12 (3. 42%) and 219 women, 7 of 12 (3.19%). In the current study, positive IgM was not observed. Related studies conducted have shown that different results were obtained in different regions, because factors such as living conditions and climatic conditions contributed much to sero positivity of Lyme disease, and this study supported these findings.

___

  • 1. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science 1993, 260:1610–1616.
  • 2. Laboratory diagnosis of Lyme borreliosis at the Portuguese National Institute of Health (1990-2004), Euro surveillance. 2006 Oct 20;11(10)
  • 3. Steere AC. Lyme disease. The New England Journal of medicine 1989, 321, 586–596.
  • 4. Marques AR. Lyme disease: an update. Current Allergy and Asthma Reports 2001, 1(6), 541-9.
  • 5. Masuzawa T, Wilske B, Komikado T, Suzuki H, Kawabata H, Sato N, et al. Comparison of OspA serotypes for B. burgdorferi sensu lato from Japan, Europe and North America. Microbiology Immunology 1996 ; 40, 539–545.
  • 6. Nikolaeva N. The review of studies in vector ecology in Russia. Bulletin of the Institute of Maritime and Tropical Medicine in Gdynia 1996, 47, 73–83.
  • 7. Machackova M, Obornik M, Kopecky J. Effect of salivary gland extract from Ixodes ricinus ticks on the proliferation of Borrelia burgdorferi sensu stricto in vivo. Folia Parasitol (Praha) 2006, 53(2), 153-8.
  • 8. Wilske B, Schierz G, Preac-Mursic V, Weber K, Pfister HW, Einhaupl K. Serological diagnosis of erythema migrans disease and related disorders. Infection 1984, 12, 331-337.
  • 9. Steere CA, Coburn J, and Lisa Glickstein L. The emergence of Lyme disease, J Clin Invest. 2004, 113(8), 1093–1101.
  • 10. Elisabeth Ferquel e, Garnier M, Marie J, Bernède BC, Baranton G, Pérez EC and Postic D. Prevalence of Borrelia burgdorferi Sensu Lato and Anaplasmataceae Members in Ixodes ricinus Ticks in Alsace, a Focus of Lyme Borreliosis Endemicity in France, Applied and Environmental Microbiology, 2006, 72(4),3074-3078.
  • 11. Rand PW, Holman MS, Lubelczyk C, Lacombe EH, DeGaetano AT, Smith RP Jr. Thermal accumulation and the early development of Ixodes scapularis. J Vector Ecol. 2004, 29(1),164-76.
  • 12. Hu L. Lyme arthritis. Infeciont Disease Clinical North America 2005, 19, 947-961.
  • 13. Chmielewska-Badora J., Seroepidemiologic Study On Lyme Borreliosis in The Lublin Region. Annals of agricultural and environmental medicine 1998, 5,183–186.
  • 14. Cermakova Z, Ryskova O, Honegr K, Cermakova E, Hanovcova I. Diagnosis of Lyme borreliosis using enzyme immunoanalysis. Medical Science Monitor 2005, 11, 121-125.
  • 15. (http://www.scmedical.net/eng/708860.pdf). Accessed 18 January 2007
  • 16. Turkiye Cumburiyeti, Isparta Valiliği 2003-2004 Isparta Yıllığı. (http://www.isparta.gov.tr/index3.php? goster=1&b1=1&b2=1). Accessed 18 January 2007.
  • 17. Central Inteligence Agency, (http://www.cia.gov/cia/ publications/factbook/geos/tu.html). Accessed 18 January 2007.
  • 18. Republic of Turkey, Ministry of Culture and Tourism, (http://goturkey.kultur.gov.tr). Accessed 18 January 2007.
  • 19. Akdiş C, et al. Bursa erenler köyünde Borrelia burgdorferi antikorlarının IFA ile araştırılması. XXV. Türk Mikrobiyoloji Kongre Kitabı 1992, 45p.
  • 20. Mutlu G, et al. Antalya yöresinde Borrelia burgdorferi antikorlarının ve vektörlerinin araştırılması. Mikrobiyoloji Bülteni 1995, 29, 1-6, Antalya.
  • 21. Erensoy A, et al. Elazığ yöresinde Lyme (Borrelia burgdorferi)’ in yaygınlığının araştırılması. XXVII. Türk Mikrobiyoloji Kongre Kitabı 1996, 149.
  • 22. Utaş S, Kardaş Y, Doğanay M. Borrelia burgdorferi ile ilişkili olabilecek semptomları olan hasta grubunun Lyme serolojisi yönünden değerlendirilmesi. Mikrobiyoloji Bülteni 1994, 28, 106-112.
  • 23. Hızel K, Ulutan F, Aktaş F. Lyme hastalığı ile uyumlu bulgusu olan hastalarda Borrelia burgdorferi antikorlarının araştırılması. İnfeksiyon Dergisi 1997,11, 87-91.
  • 24. Aydın K, Köksal İ, Karagüzel A, Volkan S, Kaygusuz S, Çaylan R, et al. Trabzon yöresinde Lyme seropozitifliği. İnfeksiyon Dergisi 2001, 15, 141-144.
  • 25. Çelik AF, et al. Denizli yöresinde Borrelia burgdorferi antikor sıklığının araştırılması. İnfeksiyon Dergisi 2001, 15, 439-441.
  • 26. Altındiş M, Yılmaz S, Bilici D. Kuzey Kıbrıs bölgesinde Borrelia burgdorferi antikor sıklığının araştırılması. İnfeksiyon dergisi 2002, 16, 163-166.
  • 27. Dennis DT, Hayes EB, Orloski KA. Recommendations for the use of Lyme disease vaccine. MMWR (Morbidity and Mortality Weekly Report) 1999, 48, 1-25, USA.
  • 28. Masuzawa T. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia. Japanese journal of infectious diseases 2004, 57(6), 229-35.
  • 29. (Eurosurveillance weekly release: 22 June (11) 6, 2006, (http://www.eurosurveillance.org/ew/2006/ 060622.asp#1). Accessed 18 January 2007.
  • 30. Letrilliart L, Ragon B, Hanslik T, Flahault A. Lyme disease in France: a primary care-based prospective study. Epidemiology and infection 2005, 133, 935-942.
  • 31. Thomas DR, Sillis M, Coleman TJ, Kench SM, Ogden NH, Salmon RL, et al. Low rates of ehrlichiosis and Lyme borreliosis in English farmworkers. Epidemiology and infection 1998, 12, 609-614.
  • 32. Hristea A, Hristescu S, Ciufecu C, Vasile A. Seroprevalence of Borrelia burgdorferi in Romania. Eur Journal of Epidemiology 2001,17, 891-896.
  • 33. Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme Disease-United States,1992- 1998, CDC Surveillance Summaries. MMWR (Morbidity and Mortality Weekly Report) 2000, 49, 1-12.